FdaApplication
ANDA 218142
Identifiers
- fda_app_no: ANDA218142
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS INC USA |
| application_type | ANDA |
| approval_date | 2025-08-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS |
1 product